| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/17/2009 | US20090311347 Combination therapy for bipolar disorder |
| 12/17/2009 | US20090311340 Use of xenon as neuroprotectant in a neonatal subject |
| 12/17/2009 | US20090311335 Combination of a triptan and an nsaid |
| 12/17/2009 | US20090311320 Multilayer orally disintegrating tablet |
| 12/17/2009 | US20090311317 Modified release tolterodine formulations |
| 12/17/2009 | US20090311313 Methods for treating tweak-related conditions |
| 12/17/2009 | US20090311286 Alphanizomenon Flos Aquae Preparation, Extracts and Purified Components Thereof for the Treatment of Neurological, Neurodegenerative and Mood Disorders |
| 12/17/2009 | US20090311281 Novel method for down-regulation of amyloid |
| 12/17/2009 | US20090311235 Use of Polymeric Materials with Other Substances for Improved Performance |
| 12/17/2009 | US20090311230 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 12/17/2009 | US20090311222 Transplantation of neural cells |
| 12/17/2009 | US20090311179 Selective Targeting of Apoptotic Cells |
| 12/17/2009 | CA2727859A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING ß-SECRETASE-INHIBITING ACTIVITY |
| 12/17/2009 | CA2727669A1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
| 12/17/2009 | CA2727617A1 Smoking cessation kit and method |
| 12/17/2009 | CA2727561A1 Dihydrotetrabenanzine for the treatment of anxiety |
| 12/17/2009 | CA2727546A1 Methods of treatment of bipolar disorder |
| 12/17/2009 | CA2727488A1 Tablet quickly disintegrating in the oral cavity and method for producing the same |
| 12/17/2009 | CA2727417A1 Liposomes capable of effectively binding the beta amyloid peptide |
| 12/17/2009 | CA2727389A1 5h-pyrrolo [2,3-b] pyrazine derivatives for kinase modulation, and indications therefor |
| 12/17/2009 | CA2727373A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 12/17/2009 | CA2727243A1 Branched 3- and 6-substituted quinolines as cgrp receptor antagonists |
| 12/17/2009 | CA2727242A1 Pyrazole derivatives useful as inhibitors of faah |
| 12/17/2009 | CA2727141A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 12/17/2009 | CA2727094A1 Unit dose formulations of ketorolac for intranasal administration |
| 12/17/2009 | CA2727086A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
| 12/17/2009 | CA2727022A1 Rasagiline for parkinson's disease modification |
| 12/17/2009 | CA2726666A1 Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 12/17/2009 | CA2726102A1 Tetrazole compounds as orexin receptor antagonists |
| 12/17/2009 | CA2725482A1 Controlled release formulations of pramipexole |
| 12/17/2009 | CA2725243A1 Opiorphin for use as a psychostimulant agent |
| 12/17/2009 | CA2723995A1 Compounds for treating symptoms associated with parkinson's disease |
| 12/17/2009 | CA2723991A1 Compounds for treating diseases |
| 12/17/2009 | CA2723967A1 Compounds for treating amyloidoses |
| 12/17/2009 | CA2720285A1 Pyrrolidine ether derivatives as nk3 receptor antagonists |
| 12/16/2009 | EP2133349A1 Kinase inhibitors |
| 12/16/2009 | EP2133340A1 Novel benzazepine derivatives |
| 12/16/2009 | EP2133338A1 Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine |
| 12/16/2009 | EP2133337A1 Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine |
| 12/16/2009 | EP2133335A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 12/16/2009 | EP2133333A1 New azabicyclic derivatives, method of preparing same and pharmaceutical compositions containing them |
| 12/16/2009 | EP2133325A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 12/16/2009 | EP2133078A1 Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments |
| 12/16/2009 | EP2132224A1 Cyclic receptor-associated protein (rap) peptides |
| 12/16/2009 | EP2132197A2 Substituted pyrimidines as adenosine receptor antagonists |
| 12/16/2009 | EP2132185A2 Pyrimidinyl-piperazines useful as dopamine d3/d2 receptor ligands |
| 12/16/2009 | EP2131843A2 Process for the synthesis of glyt-1 inhibitors |
| 12/16/2009 | EP2131841A1 Methods for treating acute and subchronic pain |
| 12/16/2009 | EP2131839A2 Compositions comprising derivatives of 3-phenylpyridazine for treating seizure-related disorders |
| 12/16/2009 | EP2131838A1 A medicament for treating schizophrenia comprising cilostazol |
| 12/16/2009 | EP2131837A1 Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| 12/16/2009 | EP2131827A2 Methods and compositions for treating thalamocortical dysrhythmia |
| 12/16/2009 | EP2131662A1 Process of producing tomato paste |
| 12/16/2009 | EP2131654A1 Bipyridine carboxamide orexin receptor antagonists |
| 12/16/2009 | EP1912644B1 N-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives, preparation and use thereof |
| 12/16/2009 | EP1805165B1 1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mglur3 receptor antagonists |
| 12/16/2009 | EP1778684B1 4-PIPERAZINYL-PYRIMIDINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D<sb>3</sb> RECEPTOR |
| 12/16/2009 | EP1429602B1 Methods for treating disorders using plant extracts |
| 12/16/2009 | CN101605795A Tricyclic compound and medical use thereof |
| 12/16/2009 | CN101605793A Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 12/16/2009 | CN101605792A Aza-isoindolones and their use as metabotropic glutamate receptor potentiators - 613 |
| 12/16/2009 | CN101605791A 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors |
| 12/16/2009 | CN101605790A New aminopyrrolo[1,2-a]indole et aminopyridazino[1,6-a]indole derivatives, method for preparing the same and pharmaceutical compositions containing the same |
| 12/16/2009 | CN101605769A Thiazole compound (as ppard) ligand and pharmaceutical, cosmetic and health food comprised thereof |
| 12/16/2009 | CN101605767A Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
| 12/16/2009 | CN101605764A Fast dissociating dopamine 2 receptor antagonists |
| 12/16/2009 | CN101605571A Therapeutical uses of eslicarbazepine |
| 12/16/2009 | CN101605556A TRKB agonists for treating autoimmune disorders |
| 12/16/2009 | CN101605554A Intracerebral oxidation inhibitor and use thereof |
| 12/16/2009 | CN101605552A Use of materials for treatment of central nervous system lesions |
| 12/16/2009 | CN101605545A Skin adhesive preparation comprising stabilized donepezil |
| 12/16/2009 | CN101605542A Pharmaceutical compositions and their methods of use |
| 12/16/2009 | CN101605541A Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents |
| 12/16/2009 | CN101602796A Selenium-containing active polypeptide, preparing method and application thereof |
| 12/16/2009 | CN101602786A N*-substituted adenosine derivative, preparation method thereof, drug composition and application |
| 12/16/2009 | CN101602750A (Substituted) naphthyl, (substituted) aryl, piperazinyl amidine compound |
| 12/16/2009 | CN101602731A Metalloproteinase inhibitors |
| 12/16/2009 | CN101602727A Preparation method of huperzine A |
| 12/16/2009 | CN101602708A Aryl alkanol piperidine derivative and application thereof as antidepressive medicine |
| 12/16/2009 | CN101602706A New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
| 12/16/2009 | CN101601859A Application of nattokinase in preparing cerebral protective agent type drugs |
| 12/16/2009 | CN101601852A Chinese medicine preparation for treating vascular migraine |
| 12/16/2009 | CN101601828A Eyesight-recovering traditional Chinese medicine for treating optic neuritis and optic nerve atrophy |
| 12/16/2009 | CN101601825A Preparation method of oral wine for cooling blood, expelling wind and darkening hair |
| 12/16/2009 | CN101601820A Preparation method of calamus epilepsy-removing oral wine |
| 12/16/2009 | CN101601808A Preparation method of oral wine for soothing nerves, tonifying yang and enriching blood |
| 12/16/2009 | CN101601785A Compound preparation for treating prosopoplegia and preparation process thereof |
| 12/16/2009 | CN101601778A Migraine grain for preventing and treating migraine |
| 12/16/2009 | CN101601754A Method for preparing Qingkailing capsules |
| 12/16/2009 | CN101601753A Method for preparing Qingkailing tablet |
| 12/16/2009 | CN101601748A Double-face external patch for treating facioplegia |
| 12/16/2009 | CN101601747A Manufacturing method of bamboo blade for curing epilepsy |
| 12/16/2009 | CN101601724A Preparation method of decoction for quickly correcting wry mouth and heterotropia |
| 12/16/2009 | CN101601706A Method for preparing radix sileris extractive |
| 12/16/2009 | CN101601700A Effective part extract of valeriana amurensis P.Smirn. and quality control method and medical use thereof |
| 12/16/2009 | CN101601679A Application of nicotinamide mononucleotide |
| 12/16/2009 | CN101601677A Establishment and application of model for screening medicaments for resisting heterogeneous and multi-reason senile dementias |
| 12/16/2009 | CN101601675A Pregnane steroids for use in the treatment of CNS disorders |
| 12/16/2009 | CN101601674A Pregnane steroids for use in the treatment of cns disorders |
| 12/16/2009 | CN101601664A Therapeutic patch with polysiloxane matrix comprising capsaicin and method for preparing the same |